nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.00786	0.00786	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—C2—age related macular degeneration	0.00758	0.00758	CbGpPWpGaD
Pseudoephedrine—MAOA—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00727	0.00727	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.00679	0.00679	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TLR4—age related macular degeneration	0.00657	0.00657	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—RDH8—age related macular degeneration	0.00649	0.00649	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NMNAT1—age related macular degeneration	0.00649	0.00649	CbGpPWpGaD
Pseudoephedrine—ADRB1—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00646	0.00646	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.00644	0.00644	CbGpPWpGaD
Pseudoephedrine—IL2—SHP2 signaling—VEGFA—age related macular degeneration	0.00639	0.00639	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CFH—age related macular degeneration	0.00634	0.00634	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CFB—age related macular degeneration	0.00615	0.00615	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—C9—age related macular degeneration	0.00614	0.00614	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00601	0.00601	CbGpPWpGaD
Pseudoephedrine—NFATC1—Ectoderm Differentiation—CCL2—age related macular degeneration	0.00588	0.00588	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—SQSTM1—age related macular degeneration	0.00568	0.00568	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—RPE65—age related macular degeneration	0.00567	0.00567	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—CCL2—age related macular degeneration	0.00563	0.00563	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CFI—age related macular degeneration	0.00533	0.00533	CbGpPWpGaD
Pseudoephedrine—TNF—IL23-mediated signaling events—CCL2—age related macular degeneration	0.0053	0.0053	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—C9—age related macular degeneration	0.0052	0.0052	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00504	0.00504	CbGpPWpGaD
Pseudoephedrine—IL2—Allograft Rejection—VEGFA—age related macular degeneration	0.00499	0.00499	CbGpPWpGaD
Pseudoephedrine—TNF—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00499	0.00499	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CFHR3—age related macular degeneration	0.00495	0.00495	CbGpPWpGaD
Pseudoephedrine—TNF—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00488	0.00488	CbGpPWpGaD
Pseudoephedrine—TNF—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.00479	0.00479	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—age related macular degeneration	0.00473	0.00473	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.0046	0.0046	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ABCA4—age related macular degeneration	0.00457	0.00457	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—RDH8—age related macular degeneration	0.00454	0.00454	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00453	0.00453	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CFI—age related macular degeneration	0.00451	0.00451	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00446	0.00446	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—C2—age related macular degeneration	0.00441	0.00441	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—RHO—age related macular degeneration	0.00439	0.00439	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CFHR3—age related macular degeneration	0.00419	0.00419	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—SQSTM1—age related macular degeneration	0.00412	0.00412	CbGpPWpGaD
Pseudoephedrine—TNF—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.0041	0.0041	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—CRP—age related macular degeneration	0.00406	0.00406	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—RHO—age related macular degeneration	0.00399	0.00399	CbGpPWpGaD
Pseudoephedrine—TNF—Transcriptional regulation of white adipocyte differentiation—CD36—age related macular degeneration	0.00398	0.00398	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—RHO—age related macular degeneration	0.00398	0.00398	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—RPE65—age related macular degeneration	0.00397	0.00397	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—CST3—age related macular degeneration	0.00392	0.00392	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RDH8—age related macular degeneration	0.00384	0.00384	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00374	0.00374	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—C2—age related macular degeneration	0.00373	0.00373	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—SQSTM1—age related macular degeneration	0.0037	0.0037	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—C3—age related macular degeneration	0.00369	0.00369	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CFH—age related macular degeneration	0.00369	0.00369	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00366	0.00366	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CFB—age related macular degeneration	0.00358	0.00358	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—SQSTM1—age related macular degeneration	0.00354	0.00354	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00352	0.00352	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.00351	0.00351	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—APOE—age related macular degeneration	0.00344	0.00344	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RPE65—age related macular degeneration	0.00336	0.00336	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—CCL2—age related macular degeneration	0.00334	0.00334	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00322	0.00322	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.0032	0.0032	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ABCA4—age related macular degeneration	0.0032	0.0032	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00317	0.00317	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00316	0.00316	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—SQSTM1—age related macular degeneration	0.00314	0.00314	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00313	0.00313	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CFH—age related macular degeneration	0.00312	0.00312	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CFB—age related macular degeneration	0.00303	0.00303	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—RHO—age related macular degeneration	0.00303	0.00303	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00302	0.00302	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00287	0.00287	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00286	0.00286	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00281	0.00281	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—RHO—age related macular degeneration	0.00279	0.00279	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—TLR4—age related macular degeneration	0.00275	0.00275	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ABCA4—age related macular degeneration	0.00271	0.00271	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00265	0.00265	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00259	0.00259	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00256	0.00256	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00256	0.00256	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—CCL2—age related macular degeneration	0.00256	0.00256	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00255	0.00255	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CD36—age related macular degeneration	0.00252	0.00252	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CST3—age related macular degeneration	0.00249	0.00249	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—F13B—age related macular degeneration	0.00249	0.00249	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TLR4—age related macular degeneration	0.00244	0.00244	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—RHO—age related macular degeneration	0.00244	0.00244	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00241	0.00241	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—C3—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—RHO—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—CD36—age related macular degeneration	0.00237	0.00237	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RHO—age related macular degeneration	0.00236	0.00236	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SERPING1—age related macular degeneration	0.00234	0.00234	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CRP—age related macular degeneration	0.00227	0.00227	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00227	0.00227	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00227	0.00227	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TGFBR1—age related macular degeneration	0.00223	0.00223	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—SQSTM1—age related macular degeneration	0.00219	0.00219	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00219	0.00219	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—TLR4—age related macular degeneration	0.00218	0.00218	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—TLR4—age related macular degeneration	0.00214	0.00214	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—CCL2—age related macular degeneration	0.0021	0.0021	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—RAD51B—age related macular degeneration	0.00203	0.00203	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—RHO—age related macular degeneration	0.00197	0.00197	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SLC16A8—age related macular degeneration	0.00188	0.00188	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—VEGFA—age related macular degeneration	0.00186	0.00186	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—SQSTM1—age related macular degeneration	0.00185	0.00185	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—RHO—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NMNAT1—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFBR1—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD36—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—C3—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ELOVL4—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SQSTM1—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—C3—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—RHO—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—RHO—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CRP—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFBR1—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—C3—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—TLR4—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—RHO—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD36—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—RHO—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RDH8—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SQSTM1—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—APOE—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RDH8—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—C3—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SLC16A8—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—VEGFA—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CRP—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—RHO—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NMNAT1—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—TLR4—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RPE65—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—RHO—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RPE65—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—RHO—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CCL2—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—C3—age related macular degeneration	0.000979	0.000979	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RDH8—age related macular degeneration	0.000976	0.000976	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ELOVL4—age related macular degeneration	0.000948	0.000948	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—RHO—age related macular degeneration	0.000941	0.000941	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000916	0.000916	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RDH8—age related macular degeneration	0.000907	0.000907	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—C3—age related macular degeneration	0.0009	0.0009	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CD36—age related macular degeneration	0.000899	0.000899	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RPE65—age related macular degeneration	0.000853	0.000853	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ABCA4—age related macular degeneration	0.00085	0.00085	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—APOE—age related macular degeneration	0.000838	0.000838	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.000838	0.000838	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ABCA4—age related macular degeneration	0.000831	0.000831	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KDR—age related macular degeneration	0.000821	0.000821	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00081	0.00081	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RPE65—age related macular degeneration	0.000792	0.000792	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000792	0.000792	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—C3—age related macular degeneration	0.000788	0.000788	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.000778	0.000778	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—KDR—age related macular degeneration	0.000777	0.000777	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—C3—age related macular degeneration	0.000771	0.000771	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC16A8—age related macular degeneration	0.000764	0.000764	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—C3—age related macular degeneration	0.000762	0.000762	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RHO—age related macular degeneration	0.000739	0.000739	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RHO—age related macular degeneration	0.000723	0.000723	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—APOE—age related macular degeneration	0.000709	0.000709	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000707	0.000707	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCL2—age related macular degeneration	0.000705	0.000705	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KDR—age related macular degeneration	0.000695	0.000695	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ABCA4—age related macular degeneration	0.000687	0.000687	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000655	0.000655	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.000639	0.000639	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—C3—age related macular degeneration	0.000638	0.000638	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000618	0.000618	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CCL2—age related macular degeneration	0.000617	0.000617	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000609	0.000609	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CCL2—age related macular degeneration	0.000603	0.000603	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RHO—age related macular degeneration	0.000598	0.000598	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCL2—age related macular degeneration	0.000596	0.000596	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.000593	0.000593	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—LIPC—age related macular degeneration	0.000585	0.000585	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CETP—age related macular degeneration	0.000565	0.000565	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.000559	0.000559	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.000556	0.000556	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000517	0.000517	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CCL2—age related macular degeneration	0.000499	0.000499	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000498	0.000498	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000464	0.000464	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—VEGFA—age related macular degeneration	0.000452	0.000452	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—C3—age related macular degeneration	0.000445	0.000445	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—C3—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—VEGFA—age related macular degeneration	0.000428	0.000428	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000415	0.000415	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000406	0.000406	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—C3—age related macular degeneration	0.000405	0.000405	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—C3—age related macular degeneration	0.000396	0.000396	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.000391	0.000391	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VEGFA—age related macular degeneration	0.000383	0.000383	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000377	0.000377	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000376	0.000376	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000368	0.000368	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—C3—age related macular degeneration	0.00036	0.00036	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CD36—age related macular degeneration	0.000339	0.000339	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000336	0.000336	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000335	0.000335	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—C3—age related macular degeneration	0.000327	0.000327	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL2—age related macular degeneration	0.000317	0.000317	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000312	0.000312	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL2—age related macular degeneration	0.00031	0.00031	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000304	0.000304	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000304	0.000304	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APOE—age related macular degeneration	0.000299	0.000299	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000283	0.000283	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000266	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000256	0.000256	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000255	0.000255	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000246	0.000246	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—C3—age related macular degeneration	0.000239	0.000239	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000238	0.000238	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—C3—age related macular degeneration	0.000234	0.000234	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000227	0.000227	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOE—age related macular degeneration	0.000222	0.000222	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KDR—age related macular degeneration	0.000218	0.000218	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOE—age related macular degeneration	0.000218	0.000218	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KDR—age related macular degeneration	0.000213	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOE—age related macular degeneration	0.0002	0.0002	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—C3—age related macular degeneration	0.000193	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL2—age related macular degeneration	0.000187	0.000187	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL2—age related macular degeneration	0.000183	0.000183	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOE—age related macular degeneration	0.00018	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.00018	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KDR—age related macular degeneration	0.000176	0.000176	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000167	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000164	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL2—age related macular degeneration	0.000151	0.000151	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000148	0.000148	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000141	0.000141	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOE—age related macular degeneration	0.00013	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—age related macular degeneration	0.00012	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—age related macular degeneration	0.000117	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—age related macular degeneration	9.72e-05	9.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	9.03e-05	9.03e-05	CbGpPWpGaD
